DWTX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

DWTXDogwood Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

DWTXDogwood Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

DWTX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only DWTX 3

—Serpin Pharmaunlistedsupplier

—Rejuvenation Labsunlistedsupplier

—University of Alabamaunlistedsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

DWTX, solidLLY, dashed

DWTXDogwood Therapeutics, Inc.

1.02· pre 1.05· delayed

Mkt cap$41.5MRevenue—Revenue—

LLYELI Lilly & Co

1,407.25· pre 1,426.32· delayed

Pre-marketNov 4 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 4 '26delayed

DWTXDogwood Therapeutics, Inc.

LLYELI Lilly & Co

1.02pre 1.05delayed

Price

1,407.25pre 1,426.32delayed

$41.5M

Mkt cap

$1.3T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

DWTX1.02vsLLY1,407.25Pre-marketNov 4 '26delayed